Display options
Share it on

ARYA Atheroscler. 2011;7(1):11-7.

The association between epicardial fat thickness in echocardiography and coronary restenosis in drug eluting stents.

ARYA atherosclerosis

Fariborz Nikaeen, Masoud Pourmoghadas, Hasan Shemirani, Seid Ahmad Mirdamadi, Mojtaba Akbari

Affiliations

  1. Associate Professor, Department of Cardiovascular Diseases, School of Medicine, Najaf-Abad Branch, Islamic Azad University, Isfahan, Iran.

PMID: 22577439 PMCID: PMC3347840

Abstract

BACKGROUND: The association between epicardial fat and coronary in-stent restenosis has not been evaluated. The objective of the present study was to evaluate the relationship of echocardiographic epicardial fat thickness (EFT) with restenosis in drug eluting stents (DES).

METHODS: In this study, 117 patients who underwent coronary angiography due to recurrent clinical symptoms or findings of non-invasive cardiac tests one year after stent implantation were selected. According to angiographic results, they were divided into two groups, 65 patients with in-stent restenosis (case group) and 52 patients without such finding (control group). EFT was measured perpendicularly on the free wall of the right ventricle at the end of systole in two echocardiographic views (parasternal short and long axis) at least in three cardiac cycles. The average of obtained values was determined and recorded as EFT. Furthermore, the history of hypertension, smoking and diabetes, age and sex were investigated and body mass index (BMI) of each patient was also calculated.

RESULTS: There were no significant differences in the baseline characteristics (P=0.812). Patients with in-stent restenosis did not have statistically significant difference (4.6±1.8 mm) in EFT compared to subjects with patent stents (4.5±1.8 mm; P=0.88). The above results were also confirmed using multiple linear regressions. No significant correlation was found between EFT and other clinical variables (P >0.05).

CONCLUSION: In this selected population, the risk of restenosis was not correlated with epicardial fat thickness. Future studies for determining the role of epicardial fat in development of in-stent restenosis are warranted.

Keywords: Echocardiography; Epicardial Fat Thickness; In-Stent Restenosis (ISR)

References

  1. J Clin Invest. 1996 Feb 1;97(3):769-76 - PubMed
  2. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14483-8 - PubMed
  3. Circulation. 2003 May 6;107(17):2274-9 - PubMed
  4. Int J Obes (Lond). 2008 Feb;32(2):268-74 - PubMed
  5. Obesity (Silver Spring). 2008 Apr;16(4):887-92 - PubMed
  6. Cardiovasc Diabetol. 2006 Jan 13;5:1 - PubMed
  7. Obes Res. 2003 Feb;11(2):304-10 - PubMed
  8. Circulation. 1992 Dec;86(6 Suppl):III47-52 - PubMed
  9. Am Heart J. 2007 Jun;153(6):907-17 - PubMed
  10. Prog Brain Res. 2004;146:279-89 - PubMed
  11. J Clin Endocrinol Metab. 2006 Nov;91(11):4620-7 - PubMed
  12. Circulation. 2004 Sep 7;110(10):1226-30 - PubMed
  13. N Engl J Med. 2006 Feb 2;354(5):483-95 - PubMed
  14. Intern Med. 1999 Feb;38(2):202-6 - PubMed
  15. Int J Obes (Lond). 2008 May;32(5):810-5 - PubMed
  16. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Aug;5(4):345-53 - PubMed
  17. Echocardiography. 2006 May;23(5):400-2 - PubMed
  18. Pneumologie. 1989 Sep;43(9):490-9 - PubMed
  19. Circ Res. 1998 Apr 20;82(7):810-8 - PubMed
  20. Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):536-43 - PubMed
  21. FASEB J. 2002 Jul;16(9):1057-63 - PubMed
  22. J Am Coll Cardiol. 2002 Dec 18;40(12):2082-9 - PubMed
  23. Atherosclerosis. 2006 Jun;186(2):354-9 - PubMed
  24. Atherosclerosis. 2001 Jan;154(1):237-8 - PubMed
  25. J Am Coll Cardiol. 1991 Mar 1;17(3):758-69 - PubMed
  26. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2351-8 - PubMed
  27. Circulation. 2003 Nov 18;108(20):2460-6 - PubMed
  28. Curr Diab Rep. 2003 Aug;3(4):293-8 - PubMed
  29. J Am Soc Echocardiogr. 2009 Dec;22(12):1311-9; quiz 1417-8 - PubMed
  30. Circulation. 2004 Jul 20;110(3):259-64 - PubMed

Publication Types